OCEA on OTC

Ocean Biomedical, Inc.

American pharmaceutical preparations company based in Providence. Summary from the record

Price unavailable

Last updated Oct 19, 2026.

Overview

Compare with another stock.

TickerOCEA on OTC¹
IndustryPharmaceutical Preparations¹
HeadquartersNew York, New York¹
Incorporated inDE²
Business address515 Madison Ave Suite 8078, New York, Ny 10022²
Filer category, Emerging growth company²
Legal formCorporation

See how the biggest companies compare on our leaderboards

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Financial statements

Operating income³⁴-$3.8M in 2024−76% since 2022

Net income³⁴-$9.5M in 2024−45% since 2022

Fiscal year	2022	2023	2024
Research and development	$8.4M³	$709.0K⁴	$26.0K⁴
Operating expenses	$16.1M³	$10.2M⁴	$3.8M⁴
Operating income	-$16.1M³	-$10.2M⁴	-$3.8M⁴
Interest	$691⁶	$50.0K³
Net income	-$17.4M³	-$114.5M⁴	-$9.5M⁴
Earnings per share	-$0.74³	-$4.35⁴	-$0.34⁴
Earnings per share (diluted)	-$0.74³	-$4.35⁴	-$0.34⁴
Shares (weighted, basic)	23.4M shares³	26.3M shares⁴	27.5M shares⁴
Shares (weighted, diluted)	23.4M shares³	26.3M shares⁴	27.5M shares⁴

Total assets⁶³⁴$902.0K in 2024−99% since 2021

Total liabilities⁶³⁴$98.5M in 2024+2801% since 2021

Shareholders’ equity³⁴-$97.6M in 2024+1365% since 2021

Cash⁷³⁴$200.0K in 2024

Fiscal year	2021	2022	2023	2024	2025
Cash	$0⁷		$1.0M³	$200.0K⁴
Current assets	$1.5M⁶	$1.8M³	$2.1M⁴	$812.0K⁴
Total assets	$108.7M⁶	$1.8M³	$5.5M⁴	$902.0K⁴
Accounts payable	$34.4K⁶	$11.4M³	$16.2M⁴	$15.9M⁴
Short-term debt			$3.2M⁴
Current liabilities	$246.4K⁶	$12.7M³	$30.0M⁴	$33.9M⁴
Total liabilities	$3.4M⁶	$12.7M³	$96.3M⁴	$98.5M⁴
Retained earnings	-$564.1K⁶	-$81.6M³	-$196.1M⁴	-$205.5M⁴
Shareholders’ equity	-$6.7M³	-$10.8M⁴	-$90.8M⁴	-$97.6M⁴
Shares outstanding		23.4M shares³	34.6M shares⁴	34.9M shares⁴	166.0M shares⁸

Cash from operations³⁴-$4.2M in 2024+321% since 2022

Fiscal year	2022	2023	2024
Cash from operations	-$993.0K³	-$9.4M⁴	-$4.2M⁴
Stock-based compensation	$12.4M³	$1.2M⁴	$745.0K⁴
Cash from investing	-$2.1M⁶
Cash from financing	$967.0K³	$10.4M⁴	$3.4M⁴

Compare Ocean Biomedical, Inc. with another company

Leadership

Who has led Ocean Biomedical, Inc., and when. Pick a name to see everywhere that person has worked.

Chief executive

Chief financial officer

2025

Chief executive officerElizabeth Ng Feb 17, 2023 to Feb 17, 2023⁹
Chief executive officerSurendra K. Ajjarapu Sep 20, 2021 to Dec 16, 2021¹⁰
Chief financial officerGurinder S. Kalra Feb 17, 2023 to Feb 17, 2023¹¹
Chief financial officerHoward A. Doss Sep 20, 2021 to Sep 20, 2021¹²

Board members and other officers (14)

EVP, Innov./Acad. P'ships HeadDaniel Behr Feb 17, 2023 to Feb 17, 2023¹³
Chief Strategy OfficerInderjote S. Kathuria Feb 17, 2023 to Feb 17, 2023¹⁴
Board memberElizabeth Ng Feb 17, 2023 to Feb 17, 2023⁹
Board memberJack A. Elias Feb 17, 2023 to Feb 17, 2023¹⁵
Board memberJerome Ringo Feb 17, 2023 to Feb 17, 2023¹⁶
Board memberJonathan Kurtis Feb 17, 2023 to Feb 17, 2023¹⁷
Board memberM. Michelle Berrey Feb 17, 2023 to Feb 17, 2023¹⁸
Board memberMartin D. Angle Feb 17, 2023 to Feb 17, 2023¹⁹
Board memberWilliam F. Owens Feb 17, 2023 to Feb 17, 2023²⁰
Board memberDonald G. Fell Sep 20, 2021 to Sep 20, 2021²¹
Board memberMichael L. Peterson Sep 20, 2021 to Mar 2, 2023²²
Board memberSiva Saravanan Sep 20, 2021 to Sep 20, 2021²³
Board memberSrinivasan Venkatesh Sep 20, 2021 to Sep 20, 2021²⁴
Board memberSurendra K. Ajjarapu Sep 20, 2021 to Mar 24, 2023¹⁰

Named in SEC Form D filings

People the company listed in its private-offering notices.

Executive OfficerRobert Sweeney named Jun 15, 2023²⁵
DirectorChirinjeev Kathuria named Jun 15, 2023²⁵

Former names

Ocean Biomedical, Inc./DEFeb 15, 2023 to Feb 15, 2023²
Aesther Healthcare Acquisition Corp.Jul 19, 2021 to Feb 14, 2023²

Timeline

Feb 17, 2023New chief executive Elizabeth Ng becomes CEO⁹
Sep 20, 2021New chief executive Surendra K. Ajjarapu becomes CEO¹⁰

Filings

231 filings to the SEC since October 2021: 5 annual reports, 13 quarterly reports, 78 major events, 28 insider forms, 33 large holders, 1 private raises, 73 other. The latest 20:

Aug 14, 2025NT 10-Q EDGAR
Aug 8, 202525-NSE EDGAR
Aug 5, 20258-K EDGAR
Jul 23, 20258-K EDGAR
Jul 16, 20258-K EDGAR
Jun 13, 20258-K EDGAR
May 15, 202510-Q EDGAR
Apr 29, 202510-K/A ANNUAL REPORT EDGAR
Apr 23, 20258-K EDGAR
Apr 8, 202510-K EDGAR
Apr 1, 20258-K EDGAR
Apr 1, 2025NT 10-K EDGAR
Mar 26, 20258-K EDGAR
Mar 20, 20258-K EDGAR
Mar 10, 2025DEFA14A EDGAR
Mar 10, 20258-K EDGAR
Feb 26, 20258-K EDGAR
Feb 26, 2025DEF 14A EDGAR
Feb 21, 20258-K EDGAR
Feb 14, 2025PRE 14A EDGAR

The 231 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

Ayrton Capital LLCSCHEDULE 13G/A, 2 filings Feb 14, 2024 to Feb 13, 2025²⁶
Lighthouse Investment Partners, LLCSC 13G/A, 2 filings Feb 14, 2023 to Feb 14, 2024²⁷
ATW SPAC MANAGEMENT LLCSC 13G/A, 2 filings Feb 14, 2022 to Feb 13, 2024²⁸
BOOTHBAY FUND MANAGEMENT, LLCSC 13G/A, 3 filings Feb 4, 2022 to Feb 13, 2024²⁹
First Trust Capital Management L.P.SC 13G/A, 2 filings Feb 14, 2023 to Feb 12, 2024³⁰
Polar Asset Management Partners Inc.SC 13G/A, 2 filings Feb 9, 2023 to Feb 9, 2024³¹
Saba Capital Management, L.P.SC 13G/A, 3 filings Feb 14, 2022 to Feb 7, 2024³²
Weiss Asset Management LPSC 13G/A, 3 filings Feb 7, 2022 to Jan 26, 2024³³
Aesther Healthcare Sponsor, LLCSC 13D/A, 3 filings Feb 7, 2022 to Mar 24, 2023³⁴
Poseidon Bio, LLCSC 13D, 1 filing Feb 24, 2023³⁵
Vellar Opportunities Fund Master, Ltd.SC 13G/A, 2 filings Feb 17, 2023³⁶
Shaolin Capital Management LLCSC 13G, 2 filings Feb 11, 2022 to Feb 14, 2023³⁷
Beryl Capital Management LLCSC 13G/A, 2 filings Feb 11, 2022 to Feb 10, 2023³⁸
Hudson Bay Capital Management LPSC 13G/A, 2 filings Feb 7, 2022 to Feb 6, 2023³⁹
Space Summit Capital LLCSC 13G/A, 1 filing Feb 3, 2022⁴⁰
Lawrence FeisSC 13G/A, 1 filing Dec 10, 2021⁴¹

Money raised

Private offerings the company reported to the SEC on Form D.

May 25, 2023Raised $7.6 million in a private offering of debt Form D: $27 million offered in all Form D

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGAROcean Biomedical, Inc. filings on SEC EDGAR
2
SEC EDGAROcean Biomedical, Inc. filings on SEC EDGAR
3
SEC EDGAROcean Biomedical, Inc. 10-K for fiscal 2022
4
SEC EDGAROcean Biomedical, Inc. 10-K for fiscal 2023
5
SEC EDGAROcean Biomedical, Inc. 10-Q for fiscal 2025
6
SEC EDGAROcean Biomedical, Inc. 10-K for fiscal 2022
7
SEC EDGAROcean Biomedical, Inc. 10-K for fiscal 2021
8
SEC EDGAROcean Biomedical, Inc. 10-K for fiscal 2025
9
SEC EDGARElizabeth Ng, Chief executive officer
10
SEC EDGARSurendra K. Ajjarapu, Chief executive officer
11
SEC EDGARGurinder S. Kalra, Chief financial officer
12
SEC EDGARHoward A. Doss, Chief financial officer
13
SEC EDGARDaniel Behr, EVP, Innov./Acad. P'ships Head
14
SEC EDGARInderjote S. Kathuria, Chief Strategy Officer
15
SEC EDGARJack A. Elias, Board member
16
SEC EDGARJerome Ringo, Board member
17
SEC EDGARJonathan Kurtis, Board member
18
SEC EDGARM. Michelle Berrey, Board member
19
SEC EDGARMartin D. Angle, Board member
20
SEC EDGARWilliam F. Owens, Board member
21
SEC EDGARDonald G. Fell, Board member
22
SEC EDGARMichael L. Peterson, Board member
23
SEC EDGARSiva Saravanan, Board member
24
SEC EDGARSrinivasan Venkatesh, Board member
25
SEC EDGAROcean Biomedical, Inc. Form D naming Robert Sweeney
26
SEC EDGARAyrton Capital LLC SCHEDULE 13G/A on Ocean Biomedical, Inc.
27
SEC EDGARLighthouse Investment Partners, LLC SC 13G/A on Ocean Biomedical, Inc.
28
SEC EDGARATW SPAC MANAGEMENT LLC SC 13G/A on Ocean Biomedical, Inc.
29
SEC EDGARBOOTHBAY FUND MANAGEMENT, LLC SC 13G/A on Ocean Biomedical, Inc.
30
SEC EDGARFirst Trust Capital Management L.P. SC 13G/A on Ocean Biomedical, Inc.
31
SEC EDGARPolar Asset Management Partners Inc. SC 13G/A on Ocean Biomedical, Inc.
32
SEC EDGARSaba Capital Management, L.P. SC 13G/A on Ocean Biomedical, Inc.
33
SEC EDGARWeiss Asset Management LP SC 13G/A on Ocean Biomedical, Inc.
34
SEC EDGARAesther Healthcare Sponsor, LLC SC 13D/A on Ocean Biomedical, Inc.
35
SEC EDGARPoseidon Bio, LLC SC 13D on Ocean Biomedical, Inc.
36
SEC EDGARVellar Opportunities Fund Master, Ltd. SC 13G/A on Ocean Biomedical, Inc.
37
SEC EDGARShaolin Capital Management LLC SC 13G on Ocean Biomedical, Inc.
38
SEC EDGARBeryl Capital Management LLC SC 13G/A on Ocean Biomedical, Inc.
39
SEC EDGARHudson Bay Capital Management LP SC 13G/A on Ocean Biomedical, Inc.
40
SEC EDGARSpace Summit Capital LLC SC 13G/A on Ocean Biomedical, Inc.
41
SEC EDGARLawrence Feis SC 13G/A on Ocean Biomedical, Inc.